| Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis (NCT03983252) | Brigham and Women's Hospital | 2021-12-01 |
| Self-administered Hyperinsufflation Chest on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity Deficit (NCT04563832) | Assistance Publique - Hôpitaux de Paris | 2021-11-25 |
| Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis (NCT05116540) | Hope Biosciences Research Foundation | 2021-11-24 |
| A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis (NCT05334472) | Novartis Pharmaceuticals | 2021-11-24 |
| Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis (NCT04415372) | University of Wisconsin, Madison | 2021-11-19 |
| Ocrelizumab Access by Socio-Economic Status (NCT05131984) | Brigham and Women's Hospital | 2021-11-18 |
| Retrospective Study on the Role of SCFA Modulation in Multiple Sclerosis (NCT06746896) | Prof. Massimo Filippi | 2021-11-17 |
| Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MS (NCT04874597) | Dr Recai Turkoglu | 2021-11-15 |
| MS-ResearchBiomarkerS (NCT05204459) | Cedars-Sinai Medical Center | 2021-11-11 |
| Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy (NCT05028634) | Celgene | 2021-11-11 |
| Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis (NCT04979546) | University of Alberta | 2021-11-04 |
| Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity (NCT04815967) | Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC | 2021-11-02 |
| Ultrasound-Guided Percutaneous Neuromodulation in Spasticity (NCT05053984) | Hospital Universitario de Canarias | 2021-11-02 |
| Territorial Implementation and Evaluation of a Multiple Sclerosis Expert Patient Program (NCT04988880) | Hospital Universitari Vall d'Hebron Research Institute | 2021-11-01 |
| Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple Sclerosis (NCT05075642) | ASP 7 Ragusa | 2021-11-01 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (PD) of GSK3888130B in Healthy Participants (NCT05131971) | GlaxoSmithKline | 2021-11-01 |
| The Effect Of Proprioceptive Neuromuscular Facilitation Techniqueson in Patients With Multiple Sclerosis (NCT06102148) | Nilay Comuk Balci | 2021-11-01 |
| Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability (NCT05881122) | Brock University | 2021-11-01 |
| Improving Prospective Memory Via Telehealth (NCT05129293) | Trinity Health Of New England | 2021-11-01 |
| Muscle Vibration and Fatigue in Patients With MS (NCT05783999) | IRCCS Centro Neurolesi Bonino Pulejo | 2021-10-28 |
| A Health Action Process Approach Online Intervention for People With Multiple Sclerosis (NCT05124522) | University of Illinois at Urbana-Champaign | 2021-10-25 |
| Sema 4A as a Marker for Inflammatory Disease in Multiple Sclerosis (NCT05077956) | Providence Health & Services | 2021-10-19 |
| Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis (NCT04953689) | State University of New York at Buffalo | 2021-10-19 |
| Neurogenic Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis (NCT05587101) | Koç University | 2021-10-19 |
| Development of a Novel Functional Eye-Tracking Software Application for Multiple Sclerosis (NCT05061953) | Innodem Neurosciences | 2021-10-18 |
| The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic (NCT05098600) | Faculty Hospital Kralovske Vinohrady | 2021-10-15 |
| COVID-19 Booster Vaccination in Persons With Multiple Sclerosis (NCT05081271) | Griffin Hospital | 2021-10-15 |
| Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory Diseases (NCT05088473) | Centre Hospitalier Universitaire de Nice | 2021-10-15 |
| Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases (NCT07502066) | IRCCS San Camillo, Venezia, Italy | 2021-10-14 |
| Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients (NCT04694534) | Lille Catholic University | 2021-10-08 |
| Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study (NCT06001138) | University of Edinburgh | 2021-10-07 |
| Tracking Peripheral Immune Cell Infiltration of the Brain in Central Inflammatory Disorders Using [Zr-89]Oxinate-4-labeled Leukocytes. (NCT03807973) | University of Alabama at Birmingham | 2021-10-05 |
| Creating Satisfying Engagement in Daily Life Through Coaching for People With Multiple Sclerosis (NCT04908085) | Dorothy Kessler | 2021-10-01 |
| Neurophysiological Assessment in Patients With Multiple Sclerosis (NCT04997343) | University of Roma La Sapienza | 2021-10-01 |
| Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS (NCT05029609) | Tiziana Life Sciences LTD | 2021-10-01 |
| The Effects of Vestibular Exercise and Cervical Stabilization Exercise Training on Balance and Gait in MS Patients (NCT05409599) | Sanko University | 2021-10-01 |
| Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis (NCT05447143) | Muğla Sıtkı Koçman University | 2021-09-30 |
| Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis (NCT05054140) | Immunic AG | 2021-09-30 |
| Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis (NCT04798651) | University Hospital, Bordeaux | 2021-09-30 |
| A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies (NCT05688436) | Biogen | 2021-09-24 |
| Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple Sclerosis (NCT06025903) | IRCCS San Raffaele | 2021-09-20 |
| A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab (NCT04998851) | Hoffmann-La Roche | 2021-09-16 |
| Risk Perception in Multiple Sclerosis (NCT05528666) | Novartis Pharmaceuticals | 2021-09-09 |
| iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis (NCT04147052) | Johns Hopkins University | 2021-09-03 |
| The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple Sclerosis (NCT05046535) | University of Jordan | 2021-09-01 |
| PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers (NCT04941781) | Contineum Therapeutics | 2021-09-01 |
| Fatigability in Persons With Multiple Sclerosis: Inputs From Cognition, Walking and Coordination (NCT05412043) | Hasselt University | 2021-09-01 |
| A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis (NCT04956744) | ImStem Biotechnology | 2021-08-31 |
| A Long-term Extension of Study GNC-401 (NCT05049161) | GeNeuro Innovation SAS | 2021-08-27 |
| Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility Study (NCT05057338) | Nordlandssykehuset HF | 2021-08-27 |
| Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable Device (NCT04969848) | Nantes University Hospital | 2021-08-18 |
| Multiple Sclerosis Intimacy and Sexuality Questionnaire (NCT05374031) | Bozok University | 2021-08-12 |
| A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis (NCT05704361) | Hoffmann-La Roche | 2021-08-11 |
| Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple Sclerosis (NCT04749667) | Haukeland University Hospital | 2021-08-09 |
| Expression of PARP-1 in Multiple Sclerosis Patients (NCT05196425) | Sohag University | 2021-08-01 |
| CONNECT Trial of eSupport Online Health-coach Moderated Support Groups for Multiple Sclerosis (NCT04943887) | eSupport Health | 2021-08-01 |
| COVID-19 Vaccine Biomarker Study in Multiple Sclerosis (NCT05121662) | Columbia University | 2021-07-29 |
| Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Amyloid PET-CT (NCT05783934) | Istituti Clinici Scientifici Maugeri SpA | 2021-07-27 |
| Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS (NCT04788615) | Novartis Pharmaceuticals | 2021-07-23 |
| The Therapeutic Effects of Forced Aerobic Exercise in Multiple Sclerosis (NCT04906057) | The Cleveland Clinic | 2021-07-06 |
| Neuromodulation in MS Using Translingual Stimulation (NCT05275049) | University of Saskatchewan | 2021-07-05 |
| Investigation of Hand Functions and Related Parameters in People With Multiple Sclerosis (NCT04933110) | Uğur OVACIK | 2021-07-05 |
| Thalamic Nuclei Volumes in Multiple Sclerosis (NCT05002764) | University Hospital, Bordeaux | 2021-07-01 |
| Extracorporeal Shock Wave Therapy in Enhancing Sensitivity and Postural Stability in Multiple Sclerosis (NCT07514104) | Furkan Bilek | 2021-07-01 |
| MS Relapses During COVID-19 Pandemic (NCT04858763) | Nottingham University Hospitals NHS Trust | 2021-07-01 |
| The Validity and Reliability of the Upper Extremity Exercise Testing (UULEX) in Patients With Multiple Sclerosis (NCT04979819) | Marmara University | 2021-07-01 |
| Metabolic Imaging of Neurological Disease (NCT06900244) | University of Oxford | 2021-07-01 |
| Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for MS (NCT05003388) | The Foundation for Orthopaedics and Regenerative Medicine | 2021-06-26 |
| Emotions in Multiple Sclerosis (NCT04804787) | Lille Catholic University | 2021-06-23 |
| Impact of Direct Current Electrical Stimulation on Spasticity Levels and Functional Muscle Use in MS (NCT04942938) | CommonSpirit Health | 2021-06-20 |
| Non-invasive BCI-controlled Assistive Devices (NCT05183152) | University of Texas at Austin | 2021-06-16 |
| Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice (NCT06737419) | Novartis Pharmaceuticals | 2021-06-09 |
| Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis (NCT04879628) | Sanofi | 2021-06-07 |
| Obesity and Pediatric Multiple Sclerosis (NCT04593082) | University of Virginia | 2021-06-03 |
| Comparison of the Performance of an Optimized 3D EPI SWI Sequence and a Non-EPI QSM SWI Sequence in Detecting the Central Vein Sign in Patients With Multiple Sclerosis (NCT04705870) | Fondation Ophtalmologique Adolphe de Rothschild | 2021-06-02 |
| Reading Problems Associated With Central Nervous System (CNS) Pathologies. (NCT04937725) | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA | 2021-06-01 |
| Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis (NCT04819360) | Brigitte Schürch | 2021-06-01 |
| CSF Free Kappa Light Chain for The Diagnosis of Demyelinating Disorders (NCT05347277) | Aga Khan University | 2021-06-01 |
| Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies (NCT06894940) | University of Pavia | 2021-06-01 |
| Dalfampridine in Egyptian Patients With Multiple Sclerosis (NCT05730738) | Ain Shams University | 2021-06-01 |
| Therapeutic Effects of Line Dancing in People With MS (NCT05322915) | Gazi University | 2021-06-01 |
| COVID-19 Vaccine Response in Treated MS Patients (NCT05060354) | Brigham and Women's Hospital | 2021-06-01 |
| GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders (NCT04847609) | ConvaTec Inc. | 2021-05-31 |
| Improving Social Cognition and Social Behaviour in Various Brain Disorders (NCT06330298) | University Medical Center Groningen | 2021-05-31 |
| Impact of Neuropsychological Disorders in Multiple Sclerosis (NCT04837365) | Lille Catholic University | 2021-05-21 |
| Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study (NCT04754542) | University of Colorado, Denver | 2021-05-18 |
| Adapting MHealth Technology to Improve Patient Activation (NCT04893590) | Washington University School of Medicine | 2021-05-14 |
| Validation of the French Adaptation of the MSWDQ-23 Questionnaire (NCT04860791) | Centre Hospitalier Universitaire de Nice | 2021-05-10 |
| Analysis of MS Patients Who Have Had Greater Than 60 Infusions of Natalizumab (NCT04964700) | Multiple Sclerosis Center of Northeastern New York | 2021-05-06 |
| Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T (NCT04707144) | Fondation Ophtalmologique Adolphe de Rothschild | 2021-05-06 |
| Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden (NCT05029206) | Uppsala University | 2021-05-05 |
| Internet Delivered Cognitive Rehabilitation for Mild Cognitive Impairments (NCT06973018) | Aniko Bartfai | 2021-05-02 |
| Predictive Indices of Independent Activity of Daily-living in Neurorehabilitation (NCT04691102) | I.R.C.C.S. Fondazione Santa Lucia | 2021-05-01 |
| The Effect of Self-Acupressure Application on Functional Composite and Quality of Life in Multiple Sclerosis Patients (NCT04936555) | Istanbul Sabahattin Zaim University | 2021-05-01 |
| EMDR for Depressed People With Multiple Sclerosis (NCT04875832) | Fondazione Don Carlo Gnocchi ETS | 2021-05-01 |
| Resting Postural Tremor in Multiple Sclerosis (NCT04405479) | Charles University, Czech Republic | 2021-05-01 |
| Study to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support Program (NCT04655222) | Biogen | 2021-04-30 |
| Use of Audio Recordings of Self-Hypnosis and Meditation for Fatigue Management in Multiple Sclerosis (NCT04688710) | University of Washington | 2021-04-30 |
| Telemonitoring and Connected Care Applied to Multiple Sclerose (NCT05242731) | Isala | 2021-04-29 |
| Aerobic Exercise for Remyelination in Multiple Sclerosis (NCT04539002) | Oregon Health and Science University | 2021-04-29 |